APA (7th ed.) Citation

Weiß, C., Becker, L., Friese, J., Blaschek, A., Hahn, A., Illsinger, S., . . . Probst-Schendzielorz, K. (2024, December). Efficacy and safety of gene therapy with onasemnogene abeparvovec in children with spinal muscular atrophy in the D-A-CH-region: A population-based observational studyResearch in context. The Lancet Regional Health. Europe.

Chicago Style (17th ed.) Citation

Weiß, Claudia, et al. "Efficacy and Safety of Gene Therapy with Onasemnogene Abeparvovec in Children with Spinal Muscular Atrophy in the D-A-CH-region: A Population-based Observational StudyResearch in Context." The Lancet Regional Health. Europe Dec. 2024.

MLA (9th ed.) Citation

Weiß, Claudia, et al. "Efficacy and Safety of Gene Therapy with Onasemnogene Abeparvovec in Children with Spinal Muscular Atrophy in the D-A-CH-region: A Population-based Observational StudyResearch in Context." The Lancet Regional Health. Europe, Dec. 2024.